Search
Zoetis Inc
ZTSAdd to Watchlist
72.660USD
-4.610-5.97%
Close 08-07 16:00（ET）Quotes delayed by 15 min
30.02BMarket Cap
12.03P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-5.97%
5 Days
-5.99%
1 Month
-4.76%
6 Months
-42.98%
Year to Date
-42.25%
1 Year
-50.98%
Key Figures
77.920Open
79.250High
12.78MVolume
12.03P/E TTM
10.46P/E Dynamic
2.060Dividend TTM
3.01%Turnover Ratio
77.270Prev. Close
72.190Low
523.04MTurnover
12.42P/E Static
9.27P/B
2.84%Div Yield TTM
18.07%ROA
172.23052wk High
1.40Volume Ratio
2.49BNet Profit
424.93MShares
6.0419EPS TTM
0.77Beta
67.01%ROE
72.38052wk Low
9.14%Amplitude
71.47%Gross Margin
30.02BMarket Cap
1.47Reward/Risk
1.54%Risk Rate
Recent
Analysis
Earnings
Novo Nordisk A/S Stock (NVO) Closed Up by 3.11% on Aug 6: What Investors Need To Know
• Novo Nordisk raised full-year sales and operating profit guidance amid strong metabolic drug demand. • Clinical data shows efficacy for cardiovascular and kidney diseases, expanding the potential patient base. • Current technical indicators show a neutral MACD signal and oversold Williams %R conditions.
TradingKeyThu, Aug 6
Insmed Inc Stock (INSM) Moved Up by 31.83% on Aug 6: Key Drivers Unveiled
• Insmed shares rose following positive clinical trial data and potential acquisition interest. • Analysts revised revenue models, setting an average price target of $196.74. • Technical indicators show a sell signal with the stock currently in oversold territory.
TradingKeyThu, Aug 6
Zoetis Inc's Score
-0.02vs previous score
Forecast7.40
Financial Health8.58
Technical2.69
Valuation Dimensions9.35
Institutional Confidence10.00
Risk Assessment7.34
Media Coverage
Coverage Level
35°C
Very Low
Very High
Negative
Analyst Rating
Zoetis Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
2026-08-06
Reporting Period
2026Q2
Earnings / Forecast
1.65/1.86
Revenue / Forecast
2.47B/2.50B
Zoetis Inc Profile
SectorPharmaceuticals
Ticker SymbolZTS
Number of employees13800
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.22% |
| Vanguard Portfolio Management, LLC | 5.72% |
| BlackRock Institutional Trust Company, N.A. | 5.67% |
| State Street Investment Management (US) | 4.72% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 52.29% |
| Investment Advisor/Hedge Fund | 33.37% |
| Research Firm | 4.25% |
| Insurance Company | 4.11% |
Related Instruments
-0.52%
+0.88%
+0.79%
+0.16%
+1.43%
+0.05%
+1.51%
+2.00%
+2.81%
+2.14%
+0.82%
+2.51%
+1.51%
+1.33%
-0.08%
+1.53%
0.00%
+2.61%
-0.43%
-1.08%Popular Instruments
54025.000
+171.500 (+0.32%)
29725.900
+342.000 (+1.16%)
7753.700
+48.800 (+0.63%)
15054.000
+137.000 (+0.92%)
66242.000
+726.000 (+1.11%)
6535.100
+37.500 (+0.58%)
76.008
-1.150 (-1.49%)
313.330
+0.920 (+0.29%)
223.960
+4.970 (+2.27%)
4341.700
+102.130 (+2.41%)
FAQs
What is the current price of Zoetis Inc (ZTS)?
The current price of Zoetis Inc (ZTS) is 72.66.
What is the symbol of Zoetis Inc?
The ticker symbol of Zoetis Inc is ZTS.
What is the 52-week high of Zoetis Inc?
The 52-week high of Zoetis Inc is 172.23.
What is the 52-week low of Zoetis Inc?
The 52-week low of Zoetis Inc is 72.38.
What is the market capitalization of Zoetis Inc?
The market capitalization of Zoetis Inc is 30.88B.
Is Zoetis Inc (ZTS) currently rated as Buy, Hold, or Sell?
According to analysts, Zoetis Inc (ZTS) has an overall rating of Buy, with a price target of 110.75.
What is the Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS)?
The Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS) is 6.03.